Media Room

Novotech allergy clinical trial on national news Click here to view » SHARETHIS.addEntry({ title: "Channel Nine", url: "http://www.novotechmediaroom.com/mediareport1025/" }); Read More →

Prawns offer hayfever help VOLUNTEERS are wanted to trial a world-first treatment for hayfever made from prawn shells which researchers say is showing promising signs of success. Sydney-based company Novotech (http://www.novotech-cro.com/) is seeking hayfever sufferers aged 15 to 60 who are otherwise healthy to be volunteers to trial a nasal... Read more

Prawns offer hayfever help VOLUNTEERS are wanted to trial a world-first treatment for hayfever made from prawn shells which researchers say is showing promising signs of success. Sydney-based company Novotech (http://www.novotech-cro.com/) is seeking hayfever sufferers aged 15 to 60 who are otherwise healthy to be volunteers to trial a nasal... Read more

Prawns offer hayfever help VOLUNTEERS are wanted to trial a world-first treatment for hayfever made from prawn shells which researchers say is showing promising signs of success. Sydney-based company Novotech (http://www.novotech-cro.com/) is seeking hayfever sufferers aged 15 to 60 who are otherwise healthy to be volunteers to trial a nasal... Read more

Prawns offer hayfever help VOLUNTEERS are wanted to trial a world-first treatment for hayfever made from prawn shells which researchers say is showing promising signs of success. Sydney-based company Novotech (http://www.novotech-cro.com/) is seeking hayfever sufferers aged 15 to 60 who are otherwise healthy to be volunteers to trial a nasal spray... Read more

Clinical Condition Ruth Beran spoke with Australian contract research organisations and found that there is strong demand for Australian clinical trials, both from within Australia and also from overseas. It comes as little surprise to Australian contract research organisations (CROs) that Australia was ranked as the number one clinical trial... Read more

Aussie CRO Novotech Raises Round For Asian Expansion Australian contract research organization Novotech Pty. has raised A$8 million ($7.3 million) in its first round of venture financing as it looks to expand into Asia. BioPacific Ventures of New Zealand and Co-Investor Capital Partners of Australia provided the funding. Alex Safarian, president... Read more

AusBiotech report: Novotech gets $8m boost Australian contract research organisation Novotech has received an $8 million injection of capital to back expansion plans in the US and Asia. The investment, from biotech venture firms BioPacificVentures and Co-Investor Capital Partners, will assist Novotech in its plans to open an office in India by... Read more

Novotech to invest Aus $8m to set up office in India Considering the opportunities in Asia, Novotech, thelargest Australian Contract Research Organization (CRO) will set up operations in Mumbai, India with an investment of Aus $8 million. The Mumbai office will be the first Asian operations for Novotech to be operational by the end of this year. For... Read more

Venture capital backs CRO expansion IT IS not just Australian research and development companies on the march in the biotech sector, according to Australian contract research organisation Novotech, which announced yesterday that the company has attracted major new venture capital to back its expansion plans. For a licensed copy [CAL] of this... Read more

Reef overcoming medical barriers The ocean – inparticular the Great Barrier Reef – is emerging as the planet’s richest source of new drugs and medical treatments, according to leading marine ecologists For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1014 SHARETHIS.addEntry({... Read more

The Daily News Novotech to announce new investors and expansion into Asia at AusBiotech 2007. Australian biotechs will soon have an Australian CRO based in Asia with Novotech planning to open a Mumbai office by the end 2007 with more to follow in the region. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote... Read more

Due to the recent economic slowdown in the west, the outsourcing business in life sciences, especially pharmaceuticals and biopharmaceutical business, has shown a surge. Consider this. Globally, since 2001, spending by drug sponsors on clinical research services has grown 15 percent annually, outpacing the 11 percent rate for overall spending... Read more

CEO, 60 Seconds The most enjoyable part of my job is…There are multiple: discussing new projects with clients, working with smart people, robust discussions at internal meetings with multiple points of view. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1012 SHARETHIS.addEntry({ title:... Read more

Choosing The Right CRO Everything you ever wanted to know about choosing a contract research organization (CRO), but were afraid to ask—that’s basically what the folks at Sydney, Australia-based Novotech have created in their “Clinical Trials Checklist” for sponsors. Novotech, the biggest of the four Australia-based CROs, recently... Read more

Novotech releases updated “clinical trials checklist” At BIO 2007, Novotech, one of Australia’s largest owned contract research organization (CRO) with offices on the US east and west coasts, released its updated ‘Clinical Trials Checklist’ for CROs, biotech, pharma and VCs, to assist in the often challenging task... Read more